Voyageur Pharmaceuticals Stock Today

VM Stock  CAD 0.06  0.01  22.22%   

Performance

6 of 100

 
Weak
 
Strong
Modest

Odds Of Distress

Less than 46

 
High
 
Low
About Average
Voyageur Pharmaceuticals is selling for under 0.055 as of the 16th of July 2024; that is 22.22 percent increase since the beginning of the trading day. The stock's lowest day price was 0.055. Voyageur Pharmaceuticals has 46 percent odds of going through some form of financial distress in the next two years and did not have a very good performance for investor during the last 90 trading days. Equity ratings for Voyageur Pharmaceuticals are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 16th of June 2024 and ending today, the 16th of July 2024. Click here to learn more.
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
Category
Healthcare
Classification
Health Care
Voyageur Minerals Ltd., an exploration stage company, engages in acquiring, exploring, and developing mineral exploration properties. The company also has interests in the Paradox Basin and Lithium King lithium brine projects in Utah. VOYAGEUR MINERALS operates under Industrial Metals Minerals classification in Canada and is traded on TSX Venture Exchange.. The company has 138.88 M outstanding shares of which 23.62 K shares are at this time shorted by private and institutional investors with about 0.36 trading days to cover. More on Voyageur Pharmaceuticals

Voyageur Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Voyageur Pharmaceuticals' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Voyageur Pharmaceuticals or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
CEO PresidentBrent BscEng
Business ConcentrationPharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Pharmaceuticals, Industrial Metals & Minerals, Basic Materials (View all Sectors)
Voyageur Pharmaceuticals' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Voyageur Pharmaceuticals' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Debt Levels
Voyageur Pharmaceuticals can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Voyageur Pharmaceuticals' financial leverage. It provides some insight into what part of Voyageur Pharmaceuticals' total assets is financed by creditors.
Liquidity
Voyageur Pharmaceuticals cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. Voyageur Pharmaceuticals currently holds 40 K in liabilities with Debt to Equity (D/E) ratio of 28.1, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Voyageur Pharmaceuticals has a current ratio of 0.16, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Voyageur Pharmaceuticals until it has trouble settling it off, either with new capital or with free cash flow. So, Voyageur Pharmaceuticals' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Voyageur Pharmaceuticals sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Voyageur to invest in growth at high rates of return. When we think about Voyageur Pharmaceuticals' use of debt, we should always consider it together with cash and equity.

Other Cashflows From Financing Activities

(69,321.31)
Voyageur Pharmaceuticals (VM) is traded on TSX Venture Exchange in Canada and employs 3 people. Voyageur Pharmaceuticals is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 7.64 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Voyageur Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Voyageur Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Voyageur Pharmaceuticals conducts business under Pharmaceuticals sector and is part of Health Care industry. The entity has 138.88 M outstanding shares of which 23.62 K shares are at this time shorted by private and institutional investors with about 0.36 trading days to cover. Voyageur Pharmaceuticals currently holds about 27.59 K in cash with (991.25 K) of positive cash flow from operations.
Check Voyageur Pharmaceuticals Probability Of Bankruptcy
Ownership Allocation
Voyageur Pharmaceuticals maintains a total of 138.88 Million outstanding shares. Voyageur Pharmaceuticals has 10.1 % of its outstanding shares held by insiders and 0.0 % owned by institutional holders. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check Voyageur Ownership Details

Voyageur Pharmaceuticals Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. Voyageur Pharmaceuticals market risk premium is the additional return an investor will receive from holding Voyageur Pharmaceuticals long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Voyageur Pharmaceuticals. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Voyageur Pharmaceuticals' alpha and beta are two of the key measurements used to evaluate Voyageur Pharmaceuticals' performance over the market, the standard measures of volatility play an important role as well.

Voyageur Stock Against Markets

Be your own money manager

Our tools can tell you how much better you can do entering a position in Voyageur Pharmaceuticals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Pattern Recognition Now

   

Pattern Recognition

Use different Pattern Recognition models to time the market across multiple global exchanges
All  Next Launch Module

Additional Tools for Voyageur Stock Analysis

When running Voyageur Pharmaceuticals' price analysis, check to measure Voyageur Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Voyageur Pharmaceuticals is operating at the current time. Most of Voyageur Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Voyageur Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Voyageur Pharmaceuticals' price. Additionally, you may evaluate how the addition of Voyageur Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.